SCHEMBL762229

SCHEMBL762229

CCCCCCOc1ccc(C)cc1

nearest known ligand 0.68

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NR5A1 Q13285 1/20 0.68
LTA4H P09960 5/20 0.60
TP53 P04637 2/20 0.59
TSHR P16473 1/20 0.59
PLA2G4B P0C869 1/20 0.58
DRD2 P14416 1/20 0.57
DRD4 P21917 1/20 0.57
DRD3 P35462 1/20 0.57
RARB P10826 3/20 0.54
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
LMNA P02545 1/20 0.54
GAA P10253 1/20 0.54
MAPT P10636 1/20 0.54
ALOX15 P16050 1/20 0.54
HSD17B10 Q99714 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14585844 1.00 NR5A1 (0.68) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL12122194 1.00 NR5A1 (0.68) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL7761726 1.00 NR5A1 (0.68) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL13991627 1.00 NR5A1 (0.68) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL14583368 1.00 NR5A1 (0.68) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL21167283 1.00 NR5A1 (0.68) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL22207170 1.00 NR5A1 (0.68) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL22207172 1.00 NR5A1 (0.68) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL22207529 1.00 NR5A1 (0.68) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL22207285 1.00 NR5A1 (0.68) NR5A1LTA4HTP53TSHRPLA2G4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12378205-B2 Process for the preparation of triazine intermediates and a process for the preparation of UV absorbers thereof BASF SE (DE) 2025-08-05 US disclosed
US-12291509-B2 Process for the preparation of UV absorbers BASF SE (DE) 2025-05-06 US disclosed
EP-3626802-B1 METHOD FOR PRODUCING LIQUID COMPOSITION SUMITOMO CHEMICAL CO (JP) 2024-12-25 EP disclosed
US-20230210006-A1 ORGANIC PHOTOVOLTAIC CELLS AND NON-FULLERENE ACCEPTORS THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2023-06-29 US disclosed
US-20230180602-A1 KEY MATERIALS FOR ORGANIC PHOTOVOLTAICS RELIABILITY UNITED STATES DEPARTMENT OF ENERGY 2023-06-08 US disclosed
EP-3908576-B1 A PROCESS FOR THE PREPARATION OF UV ABSORBERS BASF SE (DE) 2023-03-08 EP disclosed
US-20220140254-A1 KEY MATERIALS FOR ORGANIC PHOTOVOLTAICS RELIABILITY UNITED STATES DEPARTMENT OF ENERGY 2022-05-05 US disclosed
EP-3991958-A1 CURABLE COMPOSITION AND STEREOLITHOGRAPHIC RESIN COMPOSITION COMPRISING SAME Kuraray Co., Ltd. (JP) 2022-05-04 EP disclosed
US-20220119357-A1 A PROCESS FOR THE PREPARATION OF TRIAZINE INTERMEDIATES AND A PROCESS FOR THE PREPARATION OF UV ABSORBERS THEREOF BASF SE (DE) 2022-04-21 US disclosed
US-20220064129-A1 A PROCESS FOR THE PREPARATION OF UV ABSORBERS BASF CHEMICALS INDIA PVT. LTD. (IN) 2022-03-03 US disclosed
US-5622804-A COMPOSITION INCLUDING CARRIER COMPRISING ETHER COMPOUND, CHARGE DIRECTOR, DISPERSED TONER PARTICLES COMPRISING INSOLUBLE THERMOPLASTIC RESIN, COLORANT, CHARGE CONTROL AGENT FUJI XEROX CO., LTD. (JP) 1997-04-22 US disclosed
EP-0499266-B1 Endothelin antagonist TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1996-07-10 EP disclosed
US-5529874-A ETHER CARRIER LIQUID AND TONER PARTICLES DISPERSED THEREIN; SUITABLE FOR HIGH SPEED COPYING FUJI XEROX CO., LTD. (JP) 1996-06-25 US disclosed
EP-0626174-A2 Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-11-30 EP disclosed
US-5352659-A Polypeptide; hypotensive agents TAKEDA CHEMICAL INDUSTRIES (JP) 1994-10-04 US disclosed
US-5306808-A Endothelin derivatives TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-04-26 US disclosed
EP-0547317-A1 Endothelin antagonists TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-06-23 EP disclosed
EP-0499266-A1 Endothelin antagonist TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-08-19 EP disclosed
US-4315068-A CONTAINING A COBALT-AMMINE COMPLEX AND A DIOXIME OR A BISIMIDAZOLIN-3-ONE CHELATING AGENT; STABILITY; COLOR DILMS RICOH CO., LTD. (JP) 1982-02-09 US disclosed
US-4139390-A Presensitized printing plate having a print-out image EASTMAN KODAK COMPANY (US) 1979-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119357-A1 A PROCESS FOR THE PREPARATION OF TRIAZINE INTERMEDIATES AND A PROCESS FOR THE PREPARATION OF UV ABSORBERS THEREOF DHPS, NISCH, UNG NR5A1 2858/4885LTA4H 1553/4885TP53 1250/4885
US-12378205-B2 Process for the preparation of triazine intermediates and a process for the preparation of UV absorbers thereof DHPS, UNG, UMPS NR5A1 2592/4885LTA4H 1407/4885TP53 1240/4885
US-20220064129-A1 A PROCESS FOR THE PREPARATION OF UV ABSORBERS UNG, ERCC4, UROD NR5A1 2566/4885LTA4H 1221/4885TP53 1061/4885
US-20230210006-A1 ORGANIC PHOTOVOLTAIC CELLS AND NON-FULLERENE ACCEPTORS THEREOF VDAC1, KCNN4, CACNG4 NR5A1 4526/4885LTA4H 1064/4885TP53 1559/4885
US-12291509-B2 Process for the preparation of UV absorbers UNG, UROD, ERCC4 NR5A1 2673/4885LTA4H 1178/4885TP53 1314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.